China Universal Asset Management Co., Ltd. Arcutis Biotherapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $700 Million
- Q2 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 13,601 shares of ARQT stock, worth $127,305. This represents 0.02% of its overall portfolio holdings.
Number of Shares
13,601
Previous 18,614
26.93%
Holding current value
$127,305
Previous $184,000
31.52%
% of portfolio
0.02%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding ARQT
# of Institutions
193Shares Held
127MCall Options Held
5.43MPut Options Held
257K-
Jennison Associates LLC11.6MShares$108 Million0.07% of portfolio
-
Suvretta Capital Management, LLC New York, NY10MShares$93.6 Million3.89% of portfolio
-
Rubric Capital Management LP New York, NY9.82MShares$91.9 Million2.7% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$82.2 Million4.82% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$80.7 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $563M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...